Montezyd

Montezyd

montelukast

Manufacturer:

Zydus Healthcare Phils

Distributor:

Zydus Healthcare Phils
Concise Prescribing Info
Contents
Montelukast Na
Indications/Uses
Prevention of exercise-induced bronchospasm; relief of daytime & nighttime symptoms of seasonal & perennial allergic rhinitis.
Dosage/Direction for Use
Asthma or allergic rhinitis Adult ≥15 yr 10 mg. Childn 6-14 yr 5 mg, 2-5 yr 4 mg. All doses to be taken once daily in the evening for asthma & morning or evening for allergic rhinitis.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity.
Special Precautions
Not for treatment of acute asthma attack. Abrupt substitution for inhaled or oral corticosteroids. Clinical monitoring w/ systemic corticosteroid reduction. Pregnancy & lactation. Montezyd 4 & 5: Phenylketonuric patients.
Adverse Reactions
Montezyd 4 & 5: Headache, thirst. Montezyd 10: Abdominal pain & headache; somnolence.
Drug Interactions
Decreased AUC w/ phenobarb.
ATC Classification
R03DC03 - montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
Presentation/Packing
Form
Montezyd 10 FC tab 10 mg
Packing/Price
30's (P630/box, P21/film-coated tab)
Form
Montezyd 5 chewable tab 5 mg
Packing/Price
30's (P735/box, P24.5/chewable tab)
Form
Montezyd 4 chewable tab 4 mg
Packing/Price
30's (P23.5/chewable tab, P705/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in